Nasdaq · Financials
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
As-reported financials and recent SEC filings for CLOVER HEALTH INVESTMENTS, CORP. /DE, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.92B
Net income
$-85.5M
Net margin
-4.4%
Diluted EPS
—
ROE
-27.7%
P/E (TTM)
—
Market cap
$2.85B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B |
| Gross profit | — | — | — | — | — |
| Operating income | $-85.5M | $-45.7M | $-205.3M | $-286.7M | $-637.0M |
| Net income | $-85.5M | $-43.0M | $-213.4M | $-339.6M | $-587.8M |
| Diluted EPS | — | — | $-0.44 | $-0.71 | $-1.42 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-18
View on EDGAR →8-K2026-06-18
View on EDGAR →1442026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-16
View on EDGAR →1442026-06-16
View on EDGAR →8-K2026-06-16
View on EDGAR →42026-06-16
View on EDGAR →Go deeper on CLOV
Search CLOVER HEALTH INVESTMENTS, CORP. /DE’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.